Ovid Therapeutics Inc (OVID)
1.18
+0.06
(+5.36%)
USD |
NASDAQ |
Sep 27, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Free Cash Flow: -53.08M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -53.08M |
| March 31, 2024 | -50.50M |
| December 31, 2023 | -45.92M |
| September 30, 2023 | -43.24M |
| June 30, 2023 | -45.88M |
| March 31, 2023 | -48.61M |
| December 31, 2022 | -56.65M |
| September 30, 2022 | -59.57M |
| June 30, 2022 | -57.76M |
| March 31, 2022 | -62.63M |
| December 31, 2021 | 118.42M |
| September 30, 2021 | 115.98M |
| June 30, 2021 | 125.36M |
| March 31, 2021 | 127.53M |
| December 31, 2020 | -51.97M |
| September 30, 2020 | -54.48M |
| Date | Value |
|---|---|
| June 30, 2020 | -62.48M |
| March 31, 2020 | -57.07M |
| December 31, 2019 | -51.33M |
| September 30, 2019 | -45.22M |
| June 30, 2019 | -45.88M |
| March 31, 2019 | -45.80M |
| December 31, 2018 | -45.91M |
| September 30, 2018 | -43.87M |
| June 30, 2018 | -43.04M |
| March 31, 2018 | -37.29M |
| December 31, 2017 | -31.52M |
| September 30, 2017 | -28.37M |
| June 30, 2017 | -23.73M |
| March 31, 2017 | -21.33M |
| December 31, 2016 | -17.99M |
Free Cash Flow Range, Past 5 Years
-62.63M
Minimum
Mar 2022
127.53M
Maximum
Mar 2021
-17.95M
Average
-50.92M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.628B |
| Tonix Pharmaceuticals Holding Corp | -75.58M |
| GlycoMimetics Inc | -35.72M |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.26M |
| Cash from Investing (Quarterly) | 12.82M |
| Cash from Financing (Quarterly) | 0.356M |
| Free Cash Flow Per Share (Quarterly) | -0.2023 |
| Free Cash Flow to Equity (Quarterly) | -14.40M |
| Free Cash Flow to Firm (Quarterly) | -14.40M |
| Free Cash Flow Yield | -63.53% |